Fishman Jay A LTD Johnson & Johnson Transaction History

Fishman Jay A LTD

$1.01 Billion
Q3 2024

A detailed history of Fishman Jay A LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Fishman Jay A LTD holds 33,727 shares of JNJ stock, worth $5.4 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

33,727

Previous 42,709 21.03%

Holding current value

$5.4 Million

Previous $6.24 Million 12.45%

% of portfolio

0.54%

Previous 0.66%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$145.48 - $167.38 $1.31 Million - $1.5 Million	-8,982 Reduced 21.03%	33,727 $5.47 Million
Q2 2024 Aug 05, 2024	BUY	$144.38 - $157.78 $5.32 Million - $5.81 Million	36,819 Added 625.11%	42,709 $6.24 Million
Q2 2024 Jul 31, 2024	SELL	$144.38 - $157.78 $7.78 Million - $8.5 Million	-53,866 Reduced 90.14%	5,890 $860,000
Q1 2024 Apr 23, 2024	SELL	$155.22 - $162.74 $4.07 Million - $4.26 Million	-26,199 Reduced 30.48%	59,756 $9.45 Million
Q4 2023 Jan 24, 2024	SELL	$145.6 - $158.88 $718,827 - $784,390	-4,937 Reduced 5.43%	85,955 $13.5 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $3.25 Million - $3.64 Million	-20,886 Reduced 18.69%	90,892 $14.2 Million
Q2 2023 Aug 15, 2023	SELL	$154.35 - $166.11 $4.67 Million - $5.03 Million	-30,252 Reduced 21.3%	111,778 $18.5 Million
Q1 2023 May 09, 2023	SELL	$151.05 - $180.26 $2,114 - $2,523	-14 Reduced 0.01%	142,030 $22 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $343,629 - $385,649	2,145 Added 1.53%	142,044 $25.1 Million
Q3 2022 Oct 26, 2022	BUY	$161.33 - $179.52 $309,753 - $344,678	1,920 Added 1.39%	139,899 $22.9 Million
Q2 2022 Aug 09, 2022	SELL	$168.19 - $186.01 $121,096 - $133,927	-720 Reduced 0.52%	137,979 $24.5 Million
Q1 2022 May 10, 2022	BUY	$158.14 - $179.59 $513,954 - $583,667	3,250 Added 2.4%	138,699 $24.6 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $1.16 Million - $1.28 Million	7,418 Added 5.79%	135,449 $23.2 Million
Q3 2021 Nov 08, 2021	SELL	$161.5 - $179.47 $577,362 - $641,605	-3,575 Reduced 2.72%	128,031 $20.7 Million
Q2 2021 Aug 09, 2021	BUY	$159.48 - $171.07 $395,669 - $424,424	2,481 Added 1.92%	131,606 $21.7 Million
Q1 2021 May 03, 2021	SELL	$153.07 - $170.48 $4,898 - $5,455	-32 Reduced 0.02%	129,125 $21.2 Million
Q4 2020 Feb 10, 2021	BUY	$137.11 - $157.38 $193,187 - $221,748	1,409 Added 1.1%	129,157 $20.3 Million
Q3 2020 Nov 10, 2020	SELL	$140.38 - $153.83 $431,668 - $473,027	-3,075 Reduced 2.35%	127,748 $19 Million
Q2 2020 Aug 10, 2020	SELL	$128.81 - $155.51 $171,574 - $207,139	-1,332 Reduced 1.01%	130,823 $18.4 Million
Q1 2020 May 13, 2020	SELL	$111.14 - $153.99 $2.23 Million - $3.09 Million	-20,070 Reduced 13.18%	132,155 $17.3 Million
Q1 2020 May 12, 2020	BUY	$111.14 - $153.99 $1.62 Million - $2.25 Million	14,604 Added 10.61%	152,225 $20 Million
Q4 2019 Feb 04, 2020	SELL	$127.5 - $146.44 $1.07 Million - $1.23 Million	-8,404 Reduced 5.76%	137,621 $20.1 Million
Q3 2019 Nov 05, 2019	SELL	$126.95 - $142.14 $431,630 - $483,275	-3,400 Reduced 2.28%	146,025 $18.9 Million
Q2 2019 Aug 06, 2019	SELL	$131.15 - $144.24 $367,220 - $403,872	-2,800 Reduced 1.84%	149,425 $0
Q1 2019 May 01, 2019	BUY	$125.72 - $139.79 $322,220 - $358,281	2,563 Added 1.71%	152,225 $0
Q4 2018 Feb 05, 2019	SELL	$122.84 - $147.84 $335,844 - $404,194	-2,734 Reduced 1.79%	149,662 $19.3 Million
Q3 2018 Oct 31, 2018	SELL	$121.58 - $142.88 $382,977 - $450,072	-3,150 Reduced 2.03%	152,396 $0
Q2 2018 Aug 06, 2018	SELL	$119.4 - $131.76 $17,910 - $19,764	-150 Reduced 0.1%	155,546 $0
Q1 2018 May 08, 2018	SELL	$125.1 - $148.14 $250,575 - $296,724	-2,003 Reduced 1.27%	155,696 $0
Q4 2017 Feb 05, 2018	SELL	$131.22 - $143.62 $187,644 - $205,376	-1,430 Reduced 0.9%	157,699 $0
Q3 2017 Oct 31, 2017	BUY	$129.47 - $135.38 $20.6 Million - $21.5 Million	159,129	159,129 $0

Others Institutions Holding JNJ

# of Institutions

4,219

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $419B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fishman Jay A LTD with notifications on news.

Account